Kamal Ah Al-Eryani, DDS
Maxillofacial Surgery · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 1 carrier
- Offices
- 4
- Since medical school
- 10 years
- Graduated 2016
Offices
4 locations · University of California San Francisco · UCSF Oral Medicine Clinic
Hospitals listed: UCSF Medical Center. That is not proof they admit you there this week.
Plans that list them
3 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Al-Eryani’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- UCSF Medical CenterSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of University of California Health, which runs 12 hospitalsHome of UCSF Helen Diller Family Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 4.9 (3.79 to 6.02) · 7,590 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 12.8 (11.3 to 14.4) · 2,019 cases, Jan 2024 – Dec 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 139.4 (110.22 to 168.58) · 452 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.622, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.626, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.491, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.7 to 1) · 2,336 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for UCSF Medical Center
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 3 better, 5 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.9 (3.79 to 6.02) · 7,590 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.8 (11.3 to 14.4) · 2,019 cases | Worse | Jan 2024 – Dec 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 139.4 (110.22 to 168.58) · 452 cases | Better | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.622 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.626 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.491 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.7 to 1) · 2,336 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.24 (0.58 to 1.9) · 4,689 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.89 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.5 · 85 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.1 · 132 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.6 · 454 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 618 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 380 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.7 · 5,000 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.06 to 0.38) · 15,965 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.05 to 0.35) · 17,859 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.85 (0 to 1.83) · 4,184 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2 (1.1 to 2.9) · 6,516 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.35 (4.49 to 10.21) · 3,989 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5 (3.22 to 6.77) · 4,087 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.95 (0.74 to 3.15) · 2,034 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.95 (0.63 to 1.28) · 15,431 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 399 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.899 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.689 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.224 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16 · 156 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20 · 564 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 60.3 · 160 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -9.7 · 550 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 44.1 · 660 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 667 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (4.8 to 6.7) · 2,019 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6 · 421 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 107 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.9 (11.3 to 17.1) · 3,247 cases | No different | Jan 2022 – Dec 2024 |
What patients said (3,181 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 50% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$61,470
Medicare paid this office $61,470 for 252 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 74 | $10,184 | $82 |
| Return visit (30+ min) | 50 | $8,521 | $111 |
| Short return visit (20+ min) | 64 | $6,814 | $54 |
| Return visit (30+ min) | 44 | $5,807 | $80 |
| New patient visit (30+ min) | 54 | $5,361 | $99 |
See all 13 services
| Short return visit (20+ min) | 74 | $10,184 | $82 |
| Return visit (30+ min) | 50 | $8,521 | $111 |
| Short return visit (20+ min) | 64 | $6,814 | $54 |
| Return visit (30+ min) | 44 | $5,807 | $80 |
| New patient visit (30+ min) | 54 | $5,361 | $99 |
| New patient visit (45+ min) | 32 | $4,560 | $143 |
| New patient visit (45+ min) | 29 | $3,111 | $107 |
| Biopsy of mouth | 15 | $2,821 | $141 |
| Biopsy of mouth | 19 | $1,925 | $74 |
| Biopsy of front 2/3 of tongue | 16 | $1,748 | $76 |
| New patient visit (30+ min) | 21 | $1,419 | $68 |
| Short return visit | 11 | $609 | $55 |
| X-ray of lower jaws, upper jaws and teeth | 34 | $280 | $8 |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Biopsy of mouth | – | – | – | – | 30 | 46 |
| Biopsy of front 2/3 of tongue | – | – | – | – | 12 | 23 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
252 Original Medicare patients in 2024. Average age 71 · Under 65 16% · 85 and older 5% · Women 60% · Also on Medicaid 25% · Health risk score 1.49. Above the middle of the specialty; the typical maxillofacial surgery clinician is at 1.25.
Conditions among them: High blood pressure 57% · Depression 24% · Diabetes 20% · Cancer 20% · Chronic kidney disease 19% · Coronary heart disease 17% · Atrial fibrillation 13% · Heart failure 8% · COPD 8%.
The office billed $479,234, Medicare allowed $82,668 and paid $61,470; for 710 services of 27 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 252 | 710 | 71 | 1.49 | $479,234 | $61,470 |
| 2023 | 223 | 616 | 73 | 1.35 | $392,817 | $52,002 |
| 2022 | 116 | 190 | 71 | 1.22 | $90,652 | $20,350 |
| 2021 | 29 | 47 | 65 | 1.25 | $5,737 | $3,475 |
| 2020 | 14 | 20 | 67 | 1.41 | $2,240 | $663 |
| 2019 | 16 | 29 | 69 | 1.15 | $4,307 | $2,465 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 11 services
| Return visit (30+ min) | 49 | $7,905 | $116 |
| Return visit (30+ min) | 61 | $6,969 | $77 |
| Short return visit (20+ min) | 65 | $6,822 | $78 |
| Short return visit (20+ min) | 61 | $5,597 | $53 |
| New patient visit (30+ min) | 42 | $4,124 | $98 |
| New patient visit (45+ min) | 21 | $2,972 | $142 |
| New patient visit (45+ min) | 24 | $2,712 | $113 |
| Biopsy of mouth | 21 | $2,129 | $71 |
| New patient visit (30+ min) | 22 | $1,483 | $67 |
| Biopsy of front 2/3 of tongue | 11 | $1,019 | $85 |
| X-ray of lower jaws, upper jaws and teeth | 31 | $326 | $11 |
2022: 5 services
| Return visit (30+ min) | 29 | $4,651 | $119 |
| New patient visit (45+ min) | 28 | $4,171 | $149 |
| Short return visit (20+ min) | 30 | $2,718 | $75 |
| Return visit (30+ min) | 24 | $2,440 | $87 |
| New patient visit (30+ min) | 14 | $1,320 | $94 |
2021: 2 services
| Short return visit (20+ min) | 15 | $1,311 | $73 |
| New patient visit (30+ min) | 12 | $1,040 | $87 |
2019: 1 service
| New patient visit (30+ min) | 14 | $1,164 | $83 |
Drugs they prescribed that Part D paid
$17,350
Pharmacies billed $17,350 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
679 generic and fewer than 11 brand-name prescriptions · $17,350 in drug cost · 28 antibiotic prescriptions to 21 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Clotrimazole | 190 | $5,216 | $27 |
| Dexamethasone | 142 | $2,876 | $20 |
| Gabapentin | 29 | $2,723 | $94 |
| Clobetasol Propionate | 40 | $1,513 | $38 |
| Fluocinonide | 27 | $859 | $32 |
See all 13 drugs
| Clotrimazole | 190 | $5,216 | $27 |
| Dexamethasone | 142 | $2,876 | $20 |
| Gabapentin | 29 | $2,723 | $94 |
| Clobetasol Propionate | 40 | $1,513 | $38 |
| Fluocinonide | 27 | $859 | $32 |
| Fluconazole | 13 | $827 | $64 |
| Nystatin | 31 | $638 | $21 |
| Chlorhexidine Gluconate | 76 | $533 | $7 |
| Pilocarpine | 14 | $454 | $32 |
| Lidocaine Hcl Viscous | 34 | $424 | $12 |
| Triamcinolone Acetonide | 13 | $297 | $23 |
| Amoxicillin-Clavulanate Potass | 21 | $255 | $12 |
| Nystatin-Triamcinolone | 12 | $216 | $18 |
Year by year
| 2024 | 683 | 174 | None | None | $17,350 |
| 2023 | 491 | 129 | 0% (0) | None | $13,191 |
| 2022 | 176 | 76 | 0% (0) | None | $5,881 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 8 drugs
| Clotrimazole | 94 | $3,285 | $35 |
| Dexamethasone | 84 | $2,272 | $27 |
| Nystatin | 56 | $1,276 | $23 |
| Gabapentin | 24 | $1,172 | $49 |
| Fluocinonide | 27 | $738 | $27 |
| Amoxicillin-Clavulanate Potass | 29 | $485 | $17 |
| Chlorhexidine Gluconate | 77 | $459 | $6 |
| Lidocaine Hcl Viscous | 16 | $193 | $12 |
2022: 5 drugs
| Fluocinonide | 21 | $1,275 | $61 |
| Nystatin | 35 | $1,111 | $32 |
| Dexamethasone | 24 | $961 | $40 |
| Clotrimazole | 21 | $859 | $41 |
| Chlorhexidine Gluconate | 21 | $116 | $6 |
Money from drug and device companies
$85 in 2023
A payment is not proof that care is biased.
| Merz Pharmaceuticals | None | $85 | 1 payment
|
See the published payment
| Merz Pharmaceuticals | Education · 2023-10-31 | None | $85 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 74.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1356860290
- Licence
- CA DDS101402
- Group
- University of California San Francisco · UCSF Oral Medicine Clinic
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 1223G0001X (1223G0001X)
- Mailing address
- 513 Parnassus Ave., S-722, Box 0658, San Francisco, CA, 94143
- NPI first listed
- 2017-09-12
- NPI last updated
- 2022-07-24
- NPI record certified
- 2022-07-24
This is when the NPI record was last certified, not a medical board exam.